Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
BA7927 5-LOX-IN-2Summary: 5-LOX-IN-2 is a 5-lipoxygenase inhibitor. -
BA7948 YamogeninSummary: Yamogenin (Neodiosgenin) is the diastereoisomer of Diosgenin. -
BA7994 S3QEL-2Summary: S3QEL-2 is an inhibitor of superoxide production by mitochondrial complex III. S3QEL-2 selectively inhibits superoxide production at the IIIQo site (=1.7 μM). -
BA7997 DX3-213BSummary: DX3-213B is a potent orally active oxidative phosphorylation (OXPHOS) complex I inhibitor (=3.6 nM). -
BA8137 SHP389Summary: SHP389 is a metastable inhibitor. -
BA8418 CrocetinSummary: Crocetin (Transcrocetin) is extracted from saffron. -
BA8530 MAO-B-IN-30Summary: MAO-B-IN-30 is a potent, selective inhibitor that crosses the blood-brain barrier. -
BA8685 PhellopterinSummary: Phellopterin is a natural product. -
BA9010 PF-07284892Summary: PF-07284892 (ARRY-558) is a potent orally active inhibitor. -
C8147 DaunomycinoneSummary: Daunomycinone (NSC-109351) is a metabolite of Daunomycin.

